Evidence map›Paper›PMID 28672031›Full record

ArticlePloS one2017

Polymers for binding of the gram-positive oral pathogen Streptococcus mutans.

Eugene P Magennis, Nora Francini, Francesca Mastrotto, Rosa Catania, Martin Redhead, Francisco Fernandez-Trillo, David Bradshaw, David Churchley, Klaus Winzer, Cameron Alexander and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Selective Inhibition ofAdvanced materials interfaces · 2020
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Eugene P MagennisSchool of Pharmacy, University of Nottingham, Nottingham, United Kingdom.
Nora FranciniSchool of Medicine, University of Nottingham, Nottingham, United Kingdom.
Francesca MastrottoSchool of Pharmacy, University of Nottingham, Nottingham, United Kingdom.
Rosa CataniaSchool of Pharmacy, University of Nottingham, Nottingham, United Kingdom.
Martin RedheadSchool of Pharmacy, University of Nottingham, Nottingham, United Kingdom.
Francisco Fernandez-TrilloSchool of Chemistry, Haworth Building, University of Birmingham, Edgbaston, Birmingham, United Kingdom.
David BradshawGlaxoSmithKline, St Georges Avenue, Weybridge, Surrey, United Kingdom.
David ChurchleyGlaxoSmithKline, St Georges Avenue, Weybridge, Surrey, United Kingdom.
Klaus WinzerBBSRC/EPSRC Synthetic Biology Research Centre (SBRC), School of Life Sciences, University of Nottingham, Nottingham, United Kingdom.
Cameron AlexanderSchool of Pharmacy, University of Nottingham, Nottingham, United Kingdom.
Giuseppe MantovaniSchool of Pharmacy, University of Nottingham, Nottingham, United Kingdom.ORCID http://orcid.org/0000-0002-0837-0351
University of Nottingham · GBGlaxoSmithKline (United Kingdom) · GBEngineering and Physical Sciences Research Council · GBUniversity of Birmingham · GBUniversity of Padua · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Streptococcus mutans is the most significant pathogenic bacterium implicated in the formation of dental caries and, both directly and indirectly, has been associated with severe conditions such as multiple sclerosis, cerebrovascular and peripheral artery disease. Polymers able to selectively bind S. mutans and/or inhibit its adhesion to oral tissue in a non-lethal manner would offer possibilities for addressing pathogenicity without selecting for populations resistant against bactericidal agents. In the present work two libraries of 2-(dimethylamino)ethyl methacrylate (pDMAEMA)-based polymers were synthesized with various proportions of either N,N,N-trimethylethanaminium cationic- or sulfobetaine zwitterionic groups. These copolymers where initially tested as potential macromolecular ligands for S. mutans NCTC 10449, whilst Escherichia coli MG1655 was used as Gram-negative control bacteria. pDMAEMA-derived materials with high proportions of zwitterionic repeating units were found to be selective for S. mutans, in both isolated and S. mutans-E. coli mixed bacterial cultures. Fully sulfobetainized pDMAEMA was subsequently found to bind/cluster preferentially Gram-positive S. mutans and S. aureus compared to Gram negative E. coli and V. harveyi. A key initial stage of S. mutans pathogenesis involves a lectin-mediated adhesion to the tooth surface, thus the range of potential macromolecular ligands was further expanded by investigating two glycopolymers bearing α-mannopyranoside and β-galactopyranoside pendant units. Results with these polymers indicated that preferential binding to either S. mutans or E. coli can be obtained by modulating the glycosylation pattern of the chosen multivalent ligands without incurring unacceptable cytotoxicity in a model gastrointestinal cell line. Overall, our results allowed to identify a structure-property relationship for the potential antimicrobial polymers investigated, and suggest that preferential binding to Gram-positive S. mutans could be achieved by fine-tuning of the recognition elements in the polymer ligands.

Indexed as

Bacterial AdhesionEscherichia coliHumansLigandsMouthPolymersStreptococcus mutansLigandsPolymers

Identifiers

PMID28672031
PMCPMC5495209
OpenAlexW2673714956

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.